Delivery Order SPE2DB24D2018-SPE2DB24FWUK1

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order worth $14,751.21 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $20,023.92 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division, which provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $6,715.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $108,048.33 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation for the supply of STELARA 90 MG/ML SYRINGE. The $29,832.99 firm fixed-price contract has a period of performance through September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies without a set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringes. The contract, valued at $13,857.59, has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to supply a wide...
The U.S. Defense Logistics Agency (DLA) awarded a $7,110.05 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563830621 STELARA 90 MG/ML SYRINGEML. This award is under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The $14,179.06 firm-fixed price contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a $98,742.02 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. The contract is for the supply of STELARA 90 MG/ML syringes, with a performance period through September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and healthcare programs. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB24FWUK1
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $22,481.34 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4565766161 STELARA 90 MG/ML syringes. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a broad range of pharmaceutical and medical commodities to support military healthcare programs. The contract does not have a set-aside designation and is scheduled for completion by September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply critical medical products and prescription medications to various government agencies and healthcare providers.

Generated 12/11/24, 9:36 AM